Literature DB >> 4559814

Plasma endogenous triglyceride transport in hypertriglyceridaemia and effect of a hypolipidaemic drug (SU-13437).

E A Nikkilä, M Kekki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4559814     DOI： 10.1111/j.1365-2362.1972.tb00649.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN： 0014-2972            Impact factor:   4.686


× No keyword cloud information.
  5 in total

1.  Inhibition of hormone-stimulated lipolysis by clofibrate. A possible mechanism for its hypolipidemic action.

Authors:  M A D'Costa; A Angel
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

2.  Transport of very low density lipoprotein triglycerides in varying degrees of obesity and hypertriglyceridemia.

Authors:  S M Grundy; H Y Mok; L Zech; D Steinberg; M Berman
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

3.  [Relation between serum lipoprotein metabolism and biliary lipid metabolism].

Authors:  O Leiss; K von Bergmann
Journal:  Klin Wochenschr       Date:  1983-06-15

4.  Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.

Authors:  E A Nikkilä; R Ylikahri; J K Huttunen
Journal:  Proc R Soc Med       Date:  1976

5.  Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyperlipoproteinemia;.

Authors:  K Einarsson; K Hellström; M Kallner
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.